Recombinant URA1 performs the reaction:
(S)-dihydroorotate + fumarate orotate + succinate
Key features:
Electron acceptor specificity: Uses fumarate instead of ubiquinone or NAD .
Cofactor: Binds flavin mononucleotide (FMN) as a prosthetic group .
Oxygen independence: Unlike mitochondrial Class-II DHODHs, URA1 enables pyrimidine synthesis under anaerobic conditions by coupling to cytosolic fumarate reduction .
Bacterial ancestry: Phylogenetic evidence suggests URA1 in Saccharomyces species (including S. bayanus) originated via horizontal gene transfer (HGT) from Lactobacillales .
Functional replacement: The acquired bacterial-type DHODH replaced the ancestral eukaryotic DHODH, enabling anaerobic pyrimidine biosynthesis .
Distribution: Found in S. cerevisiae, S. bayanus, and related Saccharomycetaceae but absent in earlier-diverged fungi like Candida albicans .
Recombinant URA1 has been utilized to:
Bypass mitochondrial electron transport chain (ETC) defects:
Support anaerobic growth:
Structural data: No crystal structure exists for S. bayanus URA1; predictions rely on S. cerevisiae homologs .
Regulatory mechanisms: Kinetic inhibition by orotate suggests feedback regulation, but precise physiological relevance remains uncharacterized .
Biotechnological potential: Engineered URA1 variants could optimize pyrimidine production in industrial fermentation under oxygen-limited conditions .
Catalyzes the conversion of dihydroorotate to orotate using fumarate as the electron acceptor.
Dihydroorotate dehydrogenase (DHOD) catalyzes the oxidation of (S)-dihydroorotate to orotate, which constitutes the fourth step and the only redox reaction in the de novo biosynthesis of UMP, the precursor for all pyrimidine nucleotides .
The reaction proceeds as follows:
In Saccharomyces species with family 1A DHOD enzymes like S. cerevisiae and S. bayanus, fumarate serves as the primary electron acceptor, whereas family 2 DHODs in other eukaryotes typically use quinones as electron acceptors . The cytosolic family 1A DHOD enzyme contains FMN as a cofactor, which is essential for its catalytic activity .
Methodology for investigating DHOD activity typically involves spectrophotometric assays that measure either the formation of orotate (which absorbs at 300 nm) or the reduction of the electron acceptor. For S. bayanus DHOD specifically, assays should be designed to monitor fumarate reduction to succinate.
DHOD enzymes are classified into two major families based on their structure, subcellular localization, and electron acceptor preferences:
| Family | Subfamilies | Localization | Electron Acceptor | Representative Organisms |
|---|---|---|---|---|
| Family 1 | 1A | Cytosolic | Fumarate | S. cerevisiae, S. bayanus, Lactococcus lactis |
| Family 1 | 1B | Cytosolic | NAD+ | Some bacteria |
| Family 2 | - | Membrane-bound (mitochondrial in eukaryotes) | Quinones (ultimate electron acceptor is O₂) | Most eukaryotes, S. kluyveri (which has both Family 1A and 2), Schizosaccharomyces pombe |
S. bayanus URA1 encodes a Family 1A DHOD that is functionally similar to S. cerevisiae URA1 . This classification has significant implications for experimental design, as Family 1A enzymes require different assay conditions compared to Family 2 enzymes. When working with recombinant S. bayanus DHOD, researchers should use fumarate as the electron acceptor in activity assays and buffer conditions optimized for cytosolic enzymes rather than membrane-bound proteins.
Comparative genomic and phylogenetic analyses provide compelling evidence that the URA1 gene in Saccharomyces species was acquired through horizontal gene transfer from bacteria:
Sequence similarity analysis shows that S. cerevisiae and S. bayanus URA1 are more closely related to bacterial family 1A DHODs (particularly from Lactobacillales) than to the typical eukaryotic family 2 DHODs .
The gene structure of URA1 in Saccharomyces species differs from typical eukaryotic DHOD genes but resembles bacterial homologs .
Studies with S. kluyveri revealed that this yeast species possesses both a family 1A DHOD (similar to S. cerevisiae) and a family 2 DHOD (typical of eukaryotes), suggesting that the acquisition of family 1A DHOD occurred after the divergence of the Saccharomyces lineage from the Candida albicans lineage .
The presence of URA1 correlates with the ability of Saccharomyces species to grow anaerobically, suggesting that the horizontally acquired gene provided an adaptive advantage by allowing pyrimidine synthesis without oxygen .
Research methodologies for investigating this evolutionary history include whole genome sequencing, phylogenetic tree construction, and comparative analyses of gene synteny across multiple yeast species.
The expression and regulation of URA1 in Saccharomyces species involve both species-specific and conserved mechanisms:
In S. cerevisiae, the expression of URA1 is controlled by a nuclear regulatory gene (pprX-1) that constitutively enhances the expression of URA1 as well as URA3 at the transcriptional level .
The yeast URA1 gene can be expressed in Escherichia coli, but its expression depends on the orientation of the cloned fragment and requires a prokaryotic promoter for transcription initiation .
In contrast, when URA1 is expressed from a plasmid in S. cerevisiae, its expression does not depend on the orientation of the cloned fragment, indicating that transcription involves a physiological yeast promoter cloned along with the structural part of the gene .
To study URA1 regulation, researchers typically employ techniques such as:
Northern blot analysis to quantify transcript levels
Reporter gene assays using URA1 promoter constructs
Chromatin immunoprecipitation to identify regulatory proteins binding to the URA1 promoter
Gene deletion studies to identify regulatory factors
Recombinant S. bayanus DHOD shares several biochemical properties with its S. cerevisiae homolog but may have distinct characteristics:
The enzyme exists as a homodimer in vitro, similar to recombinant S. cerevisiae DHOD .
It contains FMN as a cofactor, which is essential for its catalytic activity .
The enzyme shows competitive inhibition by the reaction product orotate, with a reported Ki of approximately 7.7 μM for S. cerevisiae DHOD .
Family 1A DHODs, including S. bayanus DHOD, use fumarate as the physiological electron acceptor, distinguishing them from other DHOD families .
Like other cytosolic DHODs, S. bayanus DHOD is expected to have optimal activity at neutral to slightly basic pH (7.0-8.0) and moderate temperatures (25-30°C).
When working with recombinant S. bayanus DHOD, researchers should consider these properties for experimental design, particularly for enzyme kinetics studies and inhibitor screening.
Cloning and expressing recombinant S. bayanus URA1 requires careful consideration of several factors to ensure optimal protein production:
Cloning strategy:
Genomic DNA extraction from S. bayanus using standard yeast protocols
PCR amplification of the complete URA1 open reading frame using primers designed based on conserved regions
Restriction enzyme digestion and ligation into an appropriate expression vector
Verification of the construct by sequencing to confirm the absence of mutations
Expression systems:
E. coli: When expressing S. bayanus URA1 in E. coli, orientation of the gene in the vector is critical, as improper orientation may result in lack of expression . Consider using vectors with strong prokaryotic promoters (T7, tac) and fusion tags to enhance solubility.
Yeast expression: For native-like expression, S. cerevisiae expression systems using vectors like pRS416 have been successfully used for URA1 homologs . When expressing in S. cerevisiae, the orientation of the cloned fragment is less critical as transcription involves a physiological yeast promoter .
Purification protocol:
Affinity chromatography using His-tag or GST-tag depending on the construct design
Ion exchange chromatography to remove contaminants
Size exclusion chromatography to obtain the native dimeric form and remove aggregates
Throughout purification, include FMN (5-10 μM) in all buffers to maintain enzyme stability
Functional validation:
Activity assays measuring the conversion of dihydroorotate to orotate using spectrophotometric methods at 300 nm, or by monitoring fumarate reduction using coupled enzyme assays.
A comprehensive characterization of S. bayanus DHOD kinetics and catalytic mechanism requires multiple experimental approaches:
Steady-state kinetics:
Determine Km and kcat values for both dihydroorotate and fumarate using varied substrate concentrations
Analyze the enzyme's ping-pong mechanism (typical for family 1A DHODs) by varying both substrates systematically
Determine product inhibition constants for orotate and succinate
Pre-steady-state kinetics:
Use stopped-flow spectroscopy to measure rates of individual steps in the reaction
Analyze flavin reduction and oxidation by monitoring absorbance changes at 450 nm
Determine rate-limiting steps in the catalytic cycle
pH and temperature dependence:
Measure enzyme activity across pH range (5.5-9.0) to identify catalytic residues
Determine temperature optima and calculate thermodynamic parameters
Structure-function studies:
Perform site-directed mutagenesis of key residues (based on homology to characterized DHODs):
Analyze mutant enzymes kinetically to determine the role of each residue
For the catalytic mechanism, studies with L. lactis DHOD (another family 1A enzyme) support a one-site ping-pong mechanism where the first half-reaction involves hydride transfer from dihydroorotate to FMN, yielding orotate and FMNH2, followed by the second half-reaction where fumarate oxidizes FMNH2 back to FMN .
Determining the three-dimensional structure of S. bayanus DHOD would provide valuable insights into its function and evolution. Here are methodological approaches:
X-ray crystallography approach:
Protein preparation:
Express recombinant protein with high purity (>95%)
Ensure homogeneity through size exclusion chromatography
Concentrate to 10-15 mg/mL for crystallization trials
Crystallization screening:
Use commercial sparse matrix screens to identify initial conditions
Optimize promising conditions by varying precipitant concentration, pH, and additives
Consider co-crystallization with ligands (dihydroorotate, orotate, FMN) to stabilize the protein
Data collection and structure determination:
Alternative structural approaches:
Cryo-electron microscopy:
Particularly useful if crystallization proves challenging
May require forming larger complexes to increase molecular weight
NMR spectroscopy:
Suitable for analyzing dynamics and ligand binding
Limited to smaller domains or fragments due to size constraints
Small-angle X-ray scattering (SAXS):
Provides low-resolution envelope of the protein in solution
Useful for confirming quaternary structure and large conformational changes
Homology modeling:
Build preliminary models based on existing structures of family 1A DHODs
Validate models through functional studies of predicted critical residues
Structural information would be particularly valuable for understanding the molecular basis of S. bayanus DHOD's specificity for fumarate as an electron acceptor and for designing specific inhibitors.
Investigating the role of S. bayanus URA1 in anaerobic growth requires specialized experimental setups and analytical approaches:
Genetic manipulation approaches:
Generate URA1 deletion mutants using CRISPR-Cas9 or homologous recombination:
Complementation studies:
Transform ura1Δ strains with vectors expressing URA1 from different species
Compare S. bayanus URA1 with S. cerevisiae URA1 and family 2 DHODs
Growth and physiological characterization:
Anaerobic cultivation:
Use anaerobic chambers or sealed vessels with oxygen-scavenging systems
Monitor growth by optical density measurements
Test growth on different carbon sources to assess metabolic flexibility
Metabolic flux analysis:
Use 13C-labeled substrates to trace metabolic pathways
Quantify pyrimidine precursors and products by LC-MS/MS
Compare aerobic vs. anaerobic metabolic profiles
Biochemical analysis:
Enzyme activity assays:
Compare DHOD activity under aerobic and anaerobic conditions
Assess the ability of different electron acceptors to support activity
Redox state analysis:
Measure NAD+/NADH and FAD/FADH2 ratios
Analyze the impact of URA1 deletion on cellular redox balance
Existing research has demonstrated that URA1 is required for anaerobic biosynthesis of uracil in S. cerevisiae, and that the family 2 DHOD from A. gossypii cannot complement uracil auxotrophy under anaerobic conditions . Similar studies with S. bayanus URA1 would provide important comparative data on the evolutionary significance of this horizontally-acquired gene.
Developing specific inhibitors of S. bayanus DHOD requires a systematic approach combining computational, biochemical, and cellular methods:
Virtual screening and in silico approaches:
Homology modeling of S. bayanus DHOD based on related family 1A DHOD structures
Molecular docking of compound libraries to identify potential binding modes
Molecular dynamics simulations to assess stability of protein-ligand complexes
Pharmacophore modeling based on known inhibitors of family 1A DHODs
Biochemical screening methods:
Primary assays:
Spectrophotometric assays measuring inhibition of dihydroorotate oxidation
Fluorescence-based assays monitoring FMNH2 oxidation
Mechanism of inhibition studies:
Steady-state kinetics with varying substrate and inhibitor concentrations
Determine inhibition constants (Ki) and inhibition types (competitive, uncompetitive, or mixed)
Binding studies:
Isothermal titration calorimetry to measure binding affinity and thermodynamics
Surface plasmon resonance to determine association and dissociation rates
Structure-activity relationship studies:
Synthesize analogs of lead compounds
Test activity against S. bayanus DHOD and related enzymes
Optimize potency, selectivity, and physicochemical properties
Selectivity profiling:
Test activity against family 2 DHODs from humans and other organisms
Assess activity against other flavoenzymes to determine specificity
Studies have shown that benzoates, as pyrimidine ring analogs, are selective inhibitors of cytosolic DHODs like those found in Saccharomyces species . This unique property could be exploited to develop species-specific antifungal agents that target the horizontally-acquired DHOD in S. bayanus without affecting the structurally distinct human enzyme.
Analyzing the genetic stability and evolutionary significance of URA1 in S. bayanus requires integration of multiple genetic, genomic, and comparative approaches:
Whole genome sequence analysis:
Compare URA1 sequences across multiple S. bayanus strains to assess intraspecies variation
Analyze GC content, codon usage, and other sequence features to detect signs of horizontal gene transfer
Examine synteny and gene neighborhood across Saccharomyces species
Experimental evolution studies:
Subject S. bayanus to long-term evolution under different selective pressures:
Aerobic vs. anaerobic conditions
Different carbon sources
Presence of pyrimidine precursors or inhibitors
Sequence URA1 and surrounding regions at various time points to detect mutations
Perform competitive fitness assays to quantify selection coefficients
Hybrid genetics approaches:
Create interspecific hybrids between S. bayanus and related species
Monitor chromosome stability during fermentation and sporulation
Track inheritance patterns of URA1 during hybrid evolution
Research has shown that in interspecific hybrids (such as between S. cerevisiae and S. uvarum), the S. uvarum Chromosome 14, which contains URA1, showed high instability with 95% of isolates losing the entire chromosome after multiple fermentation cycles . This suggests potential incompatibilities or selective pressures against maintaining both copies of URA1 in hybrid genomes, which has important implications for hybrid stability and evolution.
Engineering S. bayanus DHOD for improved or novel properties requires sophisticated protein engineering approaches:
Rational design strategies:
Structure-guided mutagenesis:
Modify residues in the active site to alter substrate specificity
Introduce mutations to enhance thermostability or solubility
Engineer the electron acceptor binding site to accommodate alternative acceptors
Domain swapping:
Create chimeric enzymes with domains from family 1B or family 2 DHODs
Evaluate functionality of hybrid enzymes under different conditions
Directed evolution approaches:
Random mutagenesis:
Error-prone PCR to generate libraries with random mutations
DNA shuffling to recombine beneficial mutations
Selection systems:
Develop growth-based selection in ura1Δ yeast under challenging conditions
Use fluorescence-activated cell sorting with activity-based fluorescent probes
High-throughput screening:
Colorimetric assays in microtiter plate format
Automated liquid handling for rapid enzyme variant characterization
Computational protein design:
Use algorithms to predict stabilizing mutations
In silico evolution to identify mutations that might alter specificity
De novo active site design for novel catalytic activities
Potential engineering goals:
Expand substrate range to include modified dihydroorotates
Engineer the ability to use alternative electron acceptors
Enhance stability for industrial applications
Create DHOD variants that function efficiently across wider temperature or pH ranges
This approach could yield engineered enzymes with applications in synthetic biology, metabolic engineering, and biocatalysis. The unique properties of family 1A DHODs, such as their ability to function under anaerobic conditions, make them particularly interesting targets for engineering efforts aimed at creating yeast strains with novel metabolic capabilities.